Cargando…
Liver transplant immunosuppression during the COVID-19 pandemic()
SARS CoV-2 infection has produced a pandemic with serious consequences for our health care system. Although liver transplant patients represent only a minority of the population, the hepatologists who follow these patients have tried to coordinate efforts to produce a protocol the management of immu...
Autores principales: | Forns, Xavier, Navasa, Miquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605728/ http://dx.doi.org/10.1016/j.gastre.2020.10.001 |
Ejemplares similares
-
Inmunosupresión en el trasplante hepático en la era covid-19
por: Forns, Xavier, et al.
Publicado: (2020) -
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance
por: Shekhtman, Louis, et al.
Publicado: (2021) -
Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen α Chain Precedes Fibrosis Progression in Patients with Liver Disease
por: Marfà, Santiago, et al.
Publicado: (2014) -
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients
por: Cano, Ainara, et al.
Publicado: (2017) -
A Gaussia Luciferase Cell-Based System to Assess the Infection of Cell Culture- and Serum-Derived Hepatitis C Virus
por: Koutsoudakis, George, et al.
Publicado: (2012)